Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization
- PMID: 40528309
- DOI: 10.1002/jpn3.70096
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization
Abstract
Acute severe colitis (ASC) is a relatively frequent manifestation in children with ulcerative colitis and one of the few emergencies in paediatric gastroenterology. A standardized proactive approach based on tight monitoring and timely medical and surgical interventions may improve patients' outcomes. We aimed to update the previous ASC guidelines using detailed recommendations and practice points, based on a systematic review of the literature and consensus of experts. These guidelines update is a joint effort of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization. A systematic search was performed in Pubmed Ovid Medline, Embase and Cochrane databases using 13 predefined PICO (patient, intervention, comparison, outcomes) based questions and 30 non-PICO based questions. Grading methodology was based on the Oxford Centre for Evidence-Based Medicine-Levels of evidence. The questions were addressed by working subgroups following an iterative consensus voting process, including three online voting meetings and one face-to-face meeting. A total of 36 recommendations and 72 practice points were endorsed with a consensus rate of at least 88% for all statements, regarding initial evaluation, monitoring, medical and surgical treatment of ASC in children. Several topics have been revised since the previous 2018 guidelines and differ from corresponding published adult guidelines. These guidelines present a comprehensive overview of the management of ASC in children, offering practical recommendations and practice points aiming to standardize clinical and surgical treatment and improve outcomes of this severe scenario.
Keywords: children; colectomy; guidelines; inflammatory bowel disease; monitoring; treatment.
© 2025 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Similar articles
-
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765-815. doi: 10.1002/jpn3.70097. Epub 2025 Jul 18. J Pediatr Gastroenterol Nutr. 2025. PMID: 40677018 Free PMC article.
-
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Am J Gastroenterol. 2011 Apr;106(4):574-88. doi: 10.1038/ajg.2010.481. Epub 2011 Jan 11. Am J Gastroenterol. 2011. PMID: 21224839
-
Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition.J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):292-310. doi: 10.1097/MPG.0000000000002036. J Pediatr Gastroenterol Nutr. 2018. PMID: 30044358
-
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
Cited by
-
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765-815. doi: 10.1002/jpn3.70097. Epub 2025 Jul 18. J Pediatr Gastroenterol Nutr. 2025. PMID: 40677018 Free PMC article.
References
REFERENCES
-
- Assa A, Rinawi F, Shamir R. The long‐term predictive properties of the Paris classification in paediatric inflammatory bowel disease patients. J Crohn's Col. 2018;12:39‐47.
-
- Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330:951‐965.
-
- Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood‐onset inflammatory bowel disease. Gastroenterology. 2008;135:1114‐1122.
-
- Jakobsen C, Bartek Jr. J, Wewer V, et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease—a population‐based study. Aliment Pharmacol Ther. 2011;34:1217‐1224.
-
- Turner D, Ruemmele FM, Orlanski‐Meyer E, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis‐an evidence‐based consensus guideline from the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;67:292‐310.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous